Genovis Q3 2024: Beat across the board - Redeye

Redeye provides an updated view on Genovis following a Q3 report that surpassed our estimates across the board. We have made slight adjustments to our model and largely reaffirm our fair value range, indicating a favorable risk/reward balance in the share.

Länk till analysen i sin helhet: https://www.redeye.se/research/1051395/genovis-q3-2024-beat-across-the-board?utm_source=finwire&utm_medium=RSS